Masked hypertension: a systematic review
The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Abstract
The purpose of this research was to review the literature on masked hypertension. Studies, reviews and editorials on masked hypertension were identified by PubMed, Pascal BioMed and Cochrane literature systematic searches. Then, we carried out a meta-analysis of the six cohort studies reporting quantitative data for masked hypertension prognosis. There is still no clear consensus definition of masked hypertension and the reproducibility of the phenomenon is unknown. Nevertheless, the prevalence of masked hypertension seems to lie between 8 and 20%, and can be up to 50% in treated hypertensive patients. Subjects with masked hypertension have a higher risk of cardiovascular accidents [hazard ratios: 1.92 (1.51-2.44)] than normotensive subjects. This is due to a possible failure to recognize and appropriately manage this particular form of hypertension, the frequent association with other risk factors and coexisting target organ damage. The remaining unresolved questions are as follows: is masked hypertension a clinical entity that requires identification and characterization or a statistical phenomenon linked to the variability of blood pressure measurements?; because screening of the entire population is not feasible, how to identify individuals with masked hypertension?; and, in the absence of randomized trial, how to treat masked hypertension?
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“conventional methods of BP assessment conducted in a clinical (office-based) setting at rest fail to identify all cases of high BP, with 8–20% of individuals with normal clinic BP having raised out-of-clinic BP (i.e., masked uncontrolled hypertension).”
From The Identification and Management of High Blood Pressure Using Exercise Blood Pressure: Current Evidence and Practical Guidance (2022) · cites this paper as [4]
In the citing paper
“and may occur in up to 20% of the general population [4], with greater prevalence in those with established disease, such as type 2 diabetes (>30%) [31].”
From The Identification and Management of High Blood Pressure Using Exercise Blood Pressure: Current Evidence and Practical Guidance (2022) · cites this paper as [4]
Citations
Cites
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Chobanian, A. V., Bakris, G. L., Black, H. R., Cushman, W. C., Green, L. A., Izzo, J. L., Jones, D. W., Materson, B. J., Oparil, S., Wright, J. T., et al. (2003) · Hypertension · doi:10.1161/01.hyp.0000107251.49515.c2 · Cited by 13,271
O'Brien, E., Asmar, R., Beilin, L., Imai, Y., Mallion, J.-M., Mancia, G., Mengden, T., Myers, M., Padfield, P., Palatini, P., et al. (2003) · Journal of Hypertension · doi:10.1097/00004872-200305000-00001 · Cited by 1,655
Dolan, E., Stanton, A., Thijs, L., Hinedi, K., Atkins, N., McClory, S., Hond, E. D., McCormack, P., Staessen, J. A., & O’Brien, E. (2005) · Hypertension · doi:10.1161/01.hyp.0000170138.56903.7a · Cited by 1,227
Prognostic Value of Ambulatory Blood-Pressure Recordings in Patients with Treated Hypertension
Clement, D. L., De Buyzere, M. L., De Bacquer, D. A., de Leeuw, P. W., Duprez, D. A., Fagard, R. H., Gheeraert, P. J., Missault, L. H., Braun, J. J., Six, R. O., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022273 · Cited by 1,085
Bobrie, G. (2004) · JAMA · doi:10.1001/jama.291.11.1342 · Cited by 842
Self-citationA general parametric approach to the meta‐analysis of randomized clinical trials
Whitehead, A., & Whitehead, J. (1991) · Statistics in Medicine · doi:10.1002/sim.4780101105 · Cited by 750
Ohkubo, T., Imai, Y., Tsuji, I., Nagai, K., Kato, J., Kikuchi, N., Nishiyama, A., Aihara, A., Sekino, M., Kikuya, M., et al. (1998) · Journal of Hypertension · doi:10.1097/00004872-199816070-00010 · Cited by 741
O'Brien, E., Asmar, R., Beilin, L., Imai, Y., Mancia, G., Mengden, T., Myers, M., Padfield, P., Palatini, P., Parati, G., et al. (2005) · Journal of Hypertension · doi:10.1097/01.hjh.0000163132.84890.c4 · Cited by 722
Mancia, G., Facchetti, R., Bombelli, M., Grassi, G., & Sega, R. (2006) · Hypertension · doi:10.1161/01.hyp.0000215363.69793.bb · Cited by 691
Research works printed but not linked: 3
- OBrien, 2003, on behalf of the European Society of Hypertension Working Group on blood pressure monitoring., J Hypertens, 21, 821
- Larkin, 1998, Isolated clinic hypertension and normotension: false positives and false negatives in the assessment of hypertension, Blood Press Monit, 3, 247
- OBrien, 2005, on behalf of the European Society of Hypertension Working Group on Blood Pressure Monitoring., J Hypertens, 23, 697
Cited by
(2013) · European Heart Journal · doi:10.1093/eurheartj/eht151 · Cited by 13,655
2018 ESC/ESH Guidelines for the management of arterial hypertension
Williams, B., Mancia, G., Spiering, W., Agabiti Rosei, E., Azizi, M., Burnier, M., Clement, D. L., Coca, A., de Simone, G., Dominiczak, A., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy339 · Cited by 10,286
Mancia, G., Fagard, R., Narkiewicz, K., Redón, J., Zanchetti, A., Böhm, M., Christiaens, T., Cifkova, R., De Backer, G., Dominiczak, A., et al. (2013) · Journal of Hypertension · doi:10.1097/01.hjh.0000431740.32696.cc · Cited by 5,655
Williams, B., Mancia, G., Spiering, W., Agabiti Rosei, E., Azizi, M., Burnier, M., Clement, D. L., Coca, A., de Simone, G., Dominiczak, A., et al. (2018) · Journal of Hypertension · doi:10.1097/hjh.0000000000001940 · Cited by 2,885
European Society of hypertension position paper on ambulatory blood pressure monitoring
O’Brien, E., Parati, G., Stergiou, G., Asmar, R., Beilin, L., Bilo, G., Clement, D., de la Sierra, A., de Leeuw, P., Dolan, E., et al. (2013) · Journal of Hypertension · doi:10.1097/hjh.0b013e328363e964 · Cited by 1,419
“This phenomenon, which is best denoted by the term ‘masked uncontrolled hypertension’, is deserving of separate consideration because patients need to be identified so that they can be offered effective therapeutic BP control throughout the 24-h period to prevent the cardiovascular consequences of uncontrolled hyperte…”
BackgroundDiretrizes Brasileiras de Hipertensão Arterial – 2020
Barroso, W. K. S., Rodrigues, C. I. S., Bortolotto, L. A., Mota-Gomes, M. A., Brandão, A. A., Feitosa, A. D. D. M., Machado, C. A., Poli-de-Figueiredo, C. E., Amodeo, C., Mion, D., et al. (2021) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20201238 · Cited by 1,068
Mancia, G., Fagard, R., Narkiewicz, K., Redon, J., Zanchetti, A., Böhm, M., Christiaens, T., Cifkova, R., De Backer, G., Dominiczak, A., et al. (2014) · Blood Pressure · doi:10.3109/08037051.2014.868629 · Cited by 739
Daskalopoulou, S. S., Rabi, D. M., Zarnke, K. B., Dasgupta, K., Nerenberg, K., Cloutier, L., Gelfer, M., Lamarre-Cliche, M., Milot, A., Bolli, P., et al. (2015) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2015.02.016 · Cited by 684
“[109,112,117].”
BackgroundInfluentialMancia, G., Fagard, R., Narkiewicz, K., Redon, J., Zanchetti, A., Böhm, M., Christiaens, T., Cifkova, R., De Backer, G., Dominiczak, A., et al. (2013) · Blood Pressure · doi:10.3109/08037051.2013.812549 · Cited by 426
Pierdomenico, S. D., & Cuccurullo, F. (2011) · American Journal of Hypertension · doi:10.1038/ajh.2010.203 · Cited by 349
Long-Term Risk of Sustained Hypertension in White-Coat or Masked Hypertension
Mancia, G., Bombelli, M., Facchetti, R., Madotto, F., Quarti-Trevano, F., Friz, H. P., Grassi, G., & Sega, R. (2009) · Hypertension · doi:10.1161/hypertensionaha.109.129882 · Cited by 307
Prehypertension—prevalence, health risks, and management strategies
Egan, B. M., & Stevens-Fabry, S. (2015) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2015.17 · Cited by 241
High prevalence of masked uncontrolled hypertension in people with treated hypertension
Banegas, J. R., Ruilope, L. M., de la Sierra, A., de la Cruz, J. J., Gorostidi, M., Segura, J., Martell, N., Garcia-Puig, J., Deanfield, J., & Williams, B. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu016 · Cited by 223
“14,18 – 20 Comparison with other studies The frequency of MH in HBPM studies ranges from 9 to 37%, and 9 to 21% based on ABPM.”
InfluentialGilbert-Ouimet, M., Trudel, X., Brisson, C., Milot, A., & Vézina, M. (2014) · Scandinavian Journal of Work, Environment & Health · doi:10.5271/sjweh.3390 · Cited by 216
Hermida, R. C., Smolensky, M. H., Ayala, D. E., Portaluppi, F., Crespo, J. J., Fabbian, F., Haus, E., Manfredini, R., Mojón, A., Moyá, A., et al. (2013) · Chronobiology International · doi:10.3109/07420528.2013.750490 · Cited by 202
“…in the guidelines themselves (Mancia et al., 2007a), on the comparison only of daytime clinic and awake-time mean BP values (Angeli et al., 2010; Bobrie et al., 2008; Fagard & Cornelissen, 2007; Gustavsen et al., 2003; Ohkubo et al., 2005; Pierdomenico & Cuccurullo, 2011; Verdecchia et al.,…”
Masked Hypertension in Diabetes Mellitus: Treatment Implications for Clinical Practice
Franklin, S. S., Thijs, L., Li, Y., Hansen, T. W., Boggia, J., Liu, Y., Asayama, K., Björklund-Bodegård, K., Ohkubo, T., Jeppesen, J., et al. (2013) · Hypertension · doi:10.1161/hypertensionaha.111.00289 · Cited by 167
de la Sierra, A., Banegas, J. R., Oliveras, A., Gorostidi, M., Segura, J., de la Cruz, J. J., Armario, P., & Ruilope, L. M. (2012) · Journal of Hypertension · doi:10.1097/hjh.0b013e328353634e · Cited by 147
“Indeed, the prognosis of treated patients controlled at the office, but with elevated 24-h BP, has been reported to be worse than that of those patients uncontrolled at the office, but with normal 24-h BP [15,16].”
BackgroundMiao, F., Wen, B., Hu, Z., Fortino, G., Wang, X.-P., Liu, Z.-D., Tang, M., & Li, Y. (2020) · Artificial Intelligence in Medicine · doi:10.1016/j.artmed.2020.101919 · Cited by 145
Prevalence of white-coat and masked hypertension in national and international registries
Gorostidi, M., Vinyoles, E., Banegas, J. R., & de la Sierra, A. (2015) · Hypertension Research · doi:10.1038/hr.2014.149 · Cited by 141
de la Sierra, A., Gorostidi, M., Banegas, J. R., Segura, J., de la Cruz, J. J., & Ruilope, L. M. (2014) · American Journal of Hypertension · doi:10.1093/ajh/hpt175 · Cited by 135
Masked Hypertension and White-Coat Hypertension in Chronic Kidney Disease: A Meta-analysis
Bangash, F., & Agarwal, R. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.05391008 · Cited by 134
“Location-dependent hypertension informs the prognosis of patients with hypertension (8,9).”
BackgroundCuffless blood pressure estimation from PPG signals and its derivatives using deep learning models
El-Hajj, C., & Kyriacou, P. A. (2021) · Biomedical Signal Processing and Control · doi:10.1016/j.bspc.2021.102984 · Cited by 149
Drager, L. F., Pedrosa, R. P., Diniz, P. M., Diegues-Silva, L., Marcondes, B., Couto, R. B., Giorgi, D. M. A., Krieger, E. M., & Lorenzi-Filho, G. (2011) · Hypertension · doi:10.1161/hypertensionaha.110.165969 · Cited by 126
Treatment of hypertension: The ESH/ESC guidelines recommendations
Cuspidi, C., Tadić, M., Grassi, G. M., & Mancia, G. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.10.003 · Cited by 140
Obstructive Sleep Apnea, Masked Hypertension, and Arterial Stiffness in Men
Drager, L. F., Diegues-Silva, L., Diniz, P. M., Bortolotto, L. A., Pedrosa, R. P., Couto, R. B., Marcondes, B., Giorgi, D. M. A., Lorenzi-Filho, G., & Krieger, E. M. (2010) · American Journal of Hypertension · doi:10.1038/ajh.2009.246 · Cited by 117
Prognostic Value of Masked Uncontrolled Hypertension: Systematic Review and Meta-Analysis
Pierdomenico, S. D., Pierdomenico, A. M., Coccina, F., Clement, D. L., De Buyzere, M. L., De Bacquer, D. A., Ben-Dov, I. Z., Vongpatanasin, W., Banegas, J. R., Ruilope, L. M., et al. (2018) · Hypertension · doi:10.1161/hypertensionaha.118.11499 · Cited by 118
Omboni, S., Aristizabal, D., De la Sierra, A., Dolan, E., Head, G., Kahan, T., Kantola, I., Kario, K., Kawecka-Jaszcz, K., Malan, L., et al. (2016) · Journal of Hypertension · doi:10.1097/hjh.0000000000001074 · Cited by 117
Capítulo 2 - Diagnóstico e Classificação
Malachias, M. V. B., Souza, W., Plavnik, F. L., Rodrigues, C., Brandão, A., Neves, M. F., Bortolotto, L. A., Franco, R., Figueiredo, C., Jardim, P., et al. (2016) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20160152 · Cited by 145
Blood Pressure Measurement and Treatment Decisions: Masked and White-Coat Hypertension
Kario, K., Thijs, L., & Staessen, J. A. (2019) · Circulation Research · doi:10.1161/circresaha.118.313219 · Cited by 110
de la Sierra, A., Banegas, J. R., Segura, J., Gorostidi, M., & Ruilope, L. M. (2012) · Journal of Hypertension · doi:10.1097/hjh.0b013e328350bb40 · Cited by 109
“ABPM has become an important tool in the diagnosis and management of hypertension, allowing the detection of isolated office and masked hypertension subtypes with specific prognostic implications [8,11,12].”
BackgroundMethodShimbo, D., Newman, J. D., & Schwartz, J. E. (2012) · American Journal of Hypertension · doi:10.1038/ajh.2012.15 · Cited by 101
Jordan, J., Kurschat, C. E., & Reuter, H. (2018) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2018.0557 · Cited by 207
Determinants of masked hypertension in the general population: the Finn-Home study
Hänninen, M.-R. A., Niiranen, T. J., Puukka, P. J., Mattila, A. K., & Jula, A. M. (2011) · Journal of Hypertension · doi:10.1097/hjh.0b013e32834a98ba · Cited by 96
Masked Uncontrolled Hypertension in CKD
Agarwal, R., Pappas, M. K., & Sinha, A. D. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015030243 · Cited by 92
Masked Hypertension: Evaluation, Prognosis, and Treatment
Angeli, F., Reboldi, G., & Verdecchia, P. (2010) · American Journal of Hypertension · doi:10.1038/ajh.2010.112 · Cited by 102
Age-Specific Differences Between Conventional and Ambulatory Daytime Blood Pressure Values
Conen, D., Aeschbacher, S., Thijs, L., Li, Y., Boggia, J., Asayama, K., Hansen, T. W., Kikuya, M., Björklund-Bodegård, K., Ohkubo, T., et al. (2014) · Hypertension · doi:10.1161/hypertensionaha.114.03957 · Cited by 91
Diaz, K. M., Veerabhadrappa, P., Brown, M. D., Whited, M. C., Dubbert, P. M., & Hickson, D. A. (2015) · American Journal of Hypertension · doi:10.1093/ajh/hpu241 · Cited by 89
“902 American Journal of Hypertension 28(7) July 2015 Diaz et al.”
BackgroundInfluentialSchwartz, J. E., Burg, M. M., Shimbo, D., Broderick, J. E., Stone, A. A., Ishikawa, J., Sloan, R., Yurgel, T., Grossman, S., & Pickering, T. G. (2016) · Circulation · doi:10.1161/circulationaha.116.023404 · Cited by 82
Untreated Masked Hypertension and Subclinical Cardiac Damage: A Systematic Review and Meta-analysis
Cuspidi, C., Sala, C., Tadic, M., Rescaldani, M., Grassi, G., & Mancia, G. (2015) · American Journal of Hypertension · doi:10.1093/ajh/hpu231 · Cited by 80
Prevalence of Hypertensive Phenotypes After Preeclampsia: A Prospective Cohort Study
Ditisheim, A., Wuerzner, G., Ponte, B., Vial, Y., Irion, O., Burnier, M., Boulvain, M., & Pechère-Bertschi, A. (2018) · Hypertension · doi:10.1161/hypertensionaha.117.09799 · Cited by 78
Sleep-Time Blood Pressure and the Prognostic Value of Isolated-Office and Masked Hypertension
Hermida, R. C., Ayala, D. E., Mojón, A., & Fernández, J. R. (2012) · American Journal of Hypertension · doi:10.1038/ajh.2011.208 · Cited by 75
Epidemiology of Masked and White-Coat Hypertension: The Family-Based SKIPOGH Study
Alwan, H., Pruijm, M., Ponte, B., Ackermann, D., Guessous, I., Ehret, G., Staessen, J. A., Asayama, K., Vuistiner, P., Younes, S. E., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092522 · Cited by 73
“Although most studies tend to use the thresholds of 140/90 mmHg for office BP and 135/85 mmHg for daytime ambulatory BP, some studies set their thresholds based on the population studied, use arbitrary thresholds, or employ thresholds that are identical for both office and ambulatory BP [4].”
BackgroundInfluentialPrevalence of Masked Hypertension Among US Adults With Nonelevated Clinic Blood Pressure
Wang, Y. C., Shimbo, D., Muntner, P., Moran, A. E., Krakoff, L. R., & Schwartz, J. E. (2017) · American Journal of Epidemiology · doi:10.1093/aje/kww237 · Cited by 72
“In 2 systematic reviews of population-based studies, the prevalence of MHT among persons with nonelevated CBP was 10%–30% (13, 14).”
BackgroundOut-of-office blood pressure monitoring in chronic kidney disease
Agarwal, R., Peixoto, A. J., Santos, S. F. F., & Zoccali, C. (2009) · Blood Pressure Monitoring · doi:10.1097/mbp.0b013e3283262f58 · Cited by 71
Hänninen, M.-R. A., Niiranen, T. J., Puukka, P. J., Johansson, J., & Jula, A. M. (2012) · Journal of Hypertension · doi:10.1097/hjh.0b013e328350a69b · Cited by 70
“Furthermore, their BP levels are between those of normotensive individuals and those of sustained hypertensive patients [6,9,14,30].”
BackgroundExaggerated blood pressure response to exercise—A new portent of masked hypertension
Kayrak, M., Bacaksiz, A., Vatankulu, M. A., Ayhan, S. S., Kaya, Z., Ari, H., Sonmez, O., & Gok, H. (2010) · Clinical and Experimental Hypertension · doi:10.3109/10641963.2010.503298 · Cited by 67
Redmond, N., Booth, J. N., Tanner, R. M., Diaz, K. M., Abdalla, M., Sims, M., Muntner, P., & Shimbo, D. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.115.002284 · Cited by 66
“It has been reported that individuals with masked hypertension have a higher risk of target organ damage and cardiovascular disease (CVD) events than individuals with sustained normotension (ie, nonelevated clinic and daytime ambulatory blood pressure).(3,4) It is unclear who should be screened for masked hypertension.”
BackgroundMasked Hypertension: Evidence of the Need to Treat
Ogedegbe, G., Agyemang, C., & Ravenell, J. E. (2010) · Current Hypertension Reports · doi:10.1007/s11906-010-0140-4 · Cited by 63
“Prognostic Significance of Masked Hypertension in Predicting Cardiovascular Morbidity and Mortality The superior predictive ability of ABPM and HBPM over office blood pressure measurement is well documented in both cross-sectional and longitudinal studies [3, 16–19].”
BackgroundMethodInfluentialAssociation of Passive Smoking With Masked Hypertension in Clinically Normotensive Nonsmokers
Makris, T. K., Thomopoulos, C., Papadopoulos, D. P., Bratsas, A., Papazachou, O., Massias, S., Michalopoulou, E., Tsioufis, C., & Stefanadis, C. (2009) · American Journal of Hypertension · doi:10.1038/ajh.2009.92 · Cited by 60
Brguljan-Hitij, J., Thijs, L., Li, Y., Hansen, T. W., Boggia, J. G., Liu, Y.-P., Asayama, K., Wei, F., Björklund‐Bodegârd, K., Gu, Y., et al. (2014) · American Journal of Hypertension · doi:10.1093/ajh/hpu002 · Cited by 63
Scuteri, A., Morrell, C. H., Orrù, M., AlGhatrif, M., Saba, P. S., Terracciano, A., Ferreli, L. A. P., Loi, F., Marongiu, M., Pilia, M. G., et al. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.04.172 · Cited by 63
“In fact, both conditions are associated with early arterial aging [1,10,25] and thus with considerably higher CVD risk.”
BackgroundHypertension in the kidney transplant recipient
Wadei, H. M., & Textor, S. C. (2010) · Transplantation Reviews · doi:10.1016/j.trre.2010.02.001 · Cited by 66
“Masked hypertension is associated with chronic kidney disease (CKD) progression and with increased cardiovascular deaths in patients with or without normal kidney function [20-23].”
BackgroundZhang, D.-Y., Guo, Q.-H., An, D.-W., Li, Y., & Wang, J.-G. (2019) · Journal of Hypertension · doi:10.1097/hjh.0000000000002109 · Cited by 55
de la Sierra, A., Vinyoles, E., Banegas, J. R., Parati, G., de la Cruz, J. J., Gorostidi, M., Segura, J., & Ruilope, L. M. (2016) · Journal of Clinical Hypertension · doi:10.1111/jch.12792 · Cited by 56
“Masked hypertension has been shown to have a worse prognosis, as it is often underdiagnosed and, consequently, undertreated.(6) BP estimates obtained by ABPM are more reproducible than those measured in the office in the shortterm, ie, by considering repeated assessments separated by a few days or weeks.”
BackgroundAn Update on Masked Hypertension
Anstey, D. E., Pugliese, D. N., Abdalla, M., Bello, N. A., Givens, R. C., & Shimbo, D. (2017) · Current Hypertension Reports · doi:10.1007/s11906-017-0792-4 · Cited by 58
Banegas, J. R., de la Cruz, J. J., Graciani, A., López‐García, E., Gijón‐Conde, T., Ruilope, L. M., & Rodriguez‐Artalejo, F. (2015) · The Journal of Clinical Hypertension · doi:10.1111/jch.12525 · Cited by 49
Body fat percentage, obesity, and their relation to the incidental risk of hypertension
Park, S. K., Ryoo, J., Oh, C., Choi, J., Chung, P., & Jung, J. Y. (2019) · Journal of Clinical Hypertension · doi:10.1111/jch.13667 · Cited by 60
The conventional versus automated measurement of blood pressure in the office (CAMBO) trial
Myers, M. G., Godwin, M. S., Dawes, M. G., Kiss, A., Tobe, S. W., & Kaczorowski, J. A. (2012) · Journal of Hypertension · doi:10.1097/hjh.0b013e328356abd3 · Cited by 48
“However, the prevalence of masked hypertension in the CAMBO trial substudy is similar to the prevalence of masked hypertension in clinical outcome research studies [4], with the present findings having the additional benefit of being more generalizable to ‘real-world’ community practice, particularly for treated patie…”
BackgroundResultKennedy, B., Lasserson, T. J., Wozniak, D. R., & Smith, I. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003531.pub4 · Cited by 47
2018 ESC/ESH Guidelines for the management of arterial hypertension
Williams, B., Mancia, G., Spiering, W., Rosei, E., Azizi, M., Burnier, M., Clement, D., Coca, A., de Simone, G., Dominiczak, A. F., et al. (2019) · Revista Española de Cardiología · doi:10.1016/j.recesp.2018.12.005 · Cited by 69
Gorostidi, M., Banegas, J. R., de la Sierra, A., Vinyoles, E., Segura, J., & Ruilope, L. M. (2016) · European Journal of Clinical Investigation · doi:10.1111/eci.12565 · Cited by 45
Trudel, X., Brisson, C., Larocque, B., & Milot, A. (2009) · Journal of Hypertension · doi:10.1097/hjh.0b013e32832cb036 · Cited by 45
Out-of-Clinic Sympathetic Activity Is Increased in Patients With Masked Uncontrolled Hypertension
Siddiqui, M., Judd, E. K., Jaeger, B. C., Bhatt, H., Dudenbostel, T., Zhang, B., Edwards, L. J., Oparil, S., & Calhoun, D. A. (2018) · Hypertension · doi:10.1161/hypertensionaha.118.11818 · Cited by 43
Ambulatory vs Office Blood Pressure Monitoring in Renal Transplant Recipients
Ahmed, J., Ozorio, V., Farrant, M. T., & van der Merwe, W. (2014) · Journal of Clinical Hypertension · doi:10.1111/jch.12448 · Cited by 40
“On the whole, we estimated with 95% confidence that mean systolic BP on ABPM was 3.6 mm Hg (0.5–6.7 mm Hg) higher than office BP.”
BackgroundInfluentialGijón‐Conde, T., Gorostidi, M., Banegas, J. R., de la Sierra, A., Segura, J., Vinyoles, E., Divisón, J. A., & Ruilope, L. M. (2019) · Hipertensión y Riesgo Vascular · doi:10.1016/j.hipert.2019.05.002 · Cited by 59
Barochiner, J., Cuffaro, P. E., Aparicio, L. S., Alfie, J., Rada, M., Morales, M. S., Galarza, C. R., & Waisman, G. D. (2013) · American Journal of Hypertension · doi:10.1093/ajh/hpt036 · Cited by 43
Masked Hypertension in the Elderly: Cross-Sectional Analysis of a Population-Based Sample
Cacciolati, C., Hanon, O., Alpérovitch, A., Dufouil, C., & Tzourio, C. (2011) · American Journal of Hypertension · doi:10.1038/ajh.2011.23 · Cited by 39
Sánchez, R. A., Boggia, J., Peñaherrera, E., Barroso, W. S., Barbosa, E., Villar, R., Cobos, L., Hernández Hernández, R., Lopez, J., Octavio, J. A., et al. (2020) · The Journal of Clinical Hypertension · doi:10.1111/jch.13816 · Cited by 38
Masked hypertension and cardiac remodeling in middle-aged endurance athletes
Trachsel, L. D., Carlen, F., Brugger, N., Seiler, C., & Wilhelm, M. (2015) · Journal of Hypertension · doi:10.1097/hjh.0000000000000558 · Cited by 37
“Assuming a prevalence of masked hypertension in our population of 20% [8], 100 athletes had to be included.”
BackgroundResultInfluentialDeterminants of masked hypertension in hypertensive patients treated in a primary care setting
Andalib, A., Akhtari, S., Rigal, R., Curnew, G., Leclerc, J. ‐., Vaillancourt, M., & Tardif, J. ‐. (2012) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2010.02407.x · Cited by 36
Working Conditions and Masked Hypertension
Landsbergis, P. A., Travis, A. R., & Schnall, P. L. (2013) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-013-0015-2 · Cited by 44
Chung, J., Robinson, C., Sheffield, L., Paramanathan, P., Yu, A., Ewusie, J. E., Sanger, S., Mitsnefes, M. M., Parekh, R. S., Sinha, M. D., et al. (2023) · Hypertension · doi:10.1161/hypertensionaha.123.20967 · Cited by 40
Egan, B. M., Kai, B., Wagner, C. S., Henderson, J. H., Chandler, A. H., & Sinopoli, A. (2016) · The Journal of Clinical Hypertension · doi:10.1111/jch.12773 · Cited by 32
“Another potential explanation is that adults with controlled aTRH have a significant proportion of masked hypertension, which is associated with a prognosis similar to that of patients with elevated BP in both the office and out-of-office settings.(25) Ambulatory BP values are unavailable to address these possibilitie…”
ResultThompson, J. E. S., Smith, W. T., Ware, L. J., Mels, C. M. C., van Rooyen, J. M., Huisman, H. W., Malan, L., Malan, N. T., Lammertyn, L., & Schutte, A. E. (2015) · Hypertension Research · doi:10.1038/hr.2015.123 · Cited by 35
Workplace Interventions Aiming to Improve Psychosocial Work Factors and Related Health
Brisson, C., Gilbert‐Ouimet, M., Duchaine, C. S., Trudel, X., & Vézina, M. (2016) · Aligning perspectives on health, safety and well-being · doi:10.1007/978-3-319-32937-6_15 · Cited by 40
High ambulatory blood pressure in male professional football players
Berge, H. M., Andersen, T. E., Solberg, E. E., & Steine, K. (2013) · British Journal of Sports Medicine · doi:10.1136/bjsports-2013-092354 · Cited by 31
Konstantopoulou, A., Konstantopoulou, P., Papargyriou, I., Liatis, S., Stergiou, G. S., & Papadogiannis, D. (2009) · Journal of Human Hypertension · doi:10.1038/jhh.2009.55 · Cited by 34
A brief submaximal isometric exercise test ‘unmasks’ systolic and diastolic masked hypertension
Koletsos, N., Δίπλα, Κ., Triantafyllou, Α., Gkaliagkousi, Ε., Sachpekidis, V., Zafeiridis, A., & Δούμα, Σ. (2018) · Journal of Hypertension · doi:10.1097/hjh.0000000000001943 · Cited by 32
“M asked hypertension (masked-HYP) or isolated ambulatory hypertension refers to normal office blood pressure (BP) and elevated out-of-office BP [1,2], and has prevalence estimates ranging from 8 to 20% in population-based studies [3,4].”
BackgroundObstructive sleep apnea and ambulatory blood pressure monitoring: current evidence and research gaps
Pio-Abreu, A., Moreno, H., & Drager, L. F. (2021) · Journal of Human Hypertension · doi:10.1038/s41371-020-00470-8 · Cited by 39
Can office blood pressure readings predict masked hypertension?
For the CKiD study group, Mitsnefes, M. M., Pierce, C. B., Flynn, J. T., Samuels, J., Dionne, J. M., Furth, S. L., & Warady, B. A. (2015) · Pediatric Nephrology · doi:10.1007/s00467-015-3212-5 · Cited by 29
“The presence of masked hypertension is independently associated with adverse outcomes, including progression of CKD and cardiovascular disease (CVD) in adults [3] and development of left ventricular hypertrophy (LVH) in children with CKD [4].”
Nocturnal blood pressure patterns and cardiovascular outcomes in patients with masked hypertension
Presta, V., Figliuzzi, I., D’Agostino, M., Citoni, B., Miceli, F., Simonelli, F., Coluccia, R., Musumeci, B., Ferrucci, A., Volpe, M., et al. (2018) · Journal of Clinical Hypertension · doi:10.1111/jch.13361 · Cited by 27
Free Leptin Is Associated With Masked Hypertension in Nonobese Subjects
Thomopoulos, C., Papadopoulos, D. P., Papazachou, O., Bratsas, A., Massias, S. S., Anastasiadis, G., Perrea, D. N., & Makris, T. K. (2009) · Hypertension · doi:10.1161/hypertensionaha.108.128041 · Cited by 27
Schultz, M. G., Currie, K. D., Hedman, K., Climie, R. E., Maiorana, A., Coombes, J. S., & Sharman, J. E. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19052819 · Cited by 27
“This is an important clinical finding since masked hypertension carries similar CVD risk to established hypertension [30] and may occur in up to 20% of the general population [4], with greater prevalence in those with established disease, such as type 2 diabetes (>30%) [31].”
BackgroundGallo, A., Mattina, A., Rosenbaum, D. H., Koch, E., Pâques, M., & Girerd, X. J. (2016) · Annales de Cardiologie et d Angéiologie · doi:10.1016/j.ancard.2016.04.021 · Cited by 27
Naser, N., Džubur, A., Durak-Nalbantić, A., Kulić, M., & Naser, A. Z. (2016) · Medical Archives · doi:10.5455/medarh.2016.70.274-279 · Cited by 30
“Hypertension causes a large direct and indirect economic burden (11-20).”
BackgroundAssociation of resistin and adiponectin with different clinical blood pressure phenotypes
Thomopoulos, C., Daskalaki, M., Papazachou, O., Rodolakis, N., Bratsas, A., Papadopoulos, D. P., Papavasileiou, M. V., Perrea, D. N., & Makris, T. (2010) · Journal of Human Hypertension · doi:10.1038/jhh.2010.22 · Cited by 27
Masked hypertension in renal transplant recipients
Kayrak, M., Gül, E. E., Kaya, C., Solak, Y., Türkmen, K., Yazıcı, R., Güney, İ., Altıntepe, L., Türk, S., & Özdemir, K. (2013) · Blood Pressure · doi:10.3109/08037051.2013.796688 · Cited by 27
“Subjects with MHT have a higher risk of cardiovascular accidents than normotensive subjects (28).”
BackgroundAmbulatory Blood Pressure Monitoring: Five Decades of More Light and Less Shadows
Nobre, F. D., & Mion, D. (2016) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20160065 · Cited by 31
Masked hypertension in newly diagnosed hypothyroidism: a pilot study
Piantanida, E., Gallo, D., Veronesi, G., Pariani, N., Masiello, E., Premoli, P., Sassi, L., Lai, A., Tanda, M. L., Ferrario, M., et al. (2016) · Journal of Endocrinological Investigation · doi:10.1007/s40618-016-0488-7 · Cited by 30
Sendra‐Lillo, J., Sabater‐Hernández, D., Sendra-Ortolá, A., & Martínez-Martínez, F. (2011) · American Journal of Hypertension · doi:10.1038/ajh.2011.207 · Cited by 26
Urinary Sodium Excretion and Ambulatory Blood Pressure Findings in Patients With Hypertension
Afşar, B., Elsürer, R., Kırkpantur, A., & Kanbay, M. (2015) · Journal of Clinical Hypertension · doi:10.1111/jch.12464 · Cited by 25
“At the same time, by using office (clinical) BP measurements and ABPM, another four group of patients are identifiable: those with (a) sustained normotension (SNT; normal BP in the office and on ABPM); (2) white-coat hypertension (WCHT; higher clinical BP but normal ABPM values); (3) masked hypertension (MHT; normal c…”
MethodLeft ventricular geometry and risk of incident hypertension
Park, S. K., Jung, J. Y., Kang, J., Chung, P., & Oh, C. (2019) · Heart · doi:10.1136/heartjnl-2018-314657 · Cited by 23
Masked Uncontrolled Hypertension Is Accompanied by Increased Out-of-Clinic Aldosterone Secretion
Siddiqui, M., Judd, E. K., Zhang, B., Dudenbostel, T., Carey, R. M., Oparil, S., & Calhoun, D. A. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.15950 · Cited by 21
Sex differences in hypertension. Do we need a sex-specific guideline?
Cífková, R., & Strilchuk, L. M. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.960336 · Cited by 33
Impact of Miscuffing During Home Blood Pressure Measurement on the Prevalence of Masked Hypertension
Mourad, J., Lopez‐Sublet, M., Bahous, S. A., Villeneuve, F., Jaboureck, O., Dourmap, C., Denolle, T., Fourcade, J., & Baguet, J.-P. (2013) · American Journal of Hypertension · doi:10.1093/ajh/hpt084 · Cited by 24
Afşar, B. (2013) · Journal of Cardiology · doi:10.1016/j.jjcc.2012.11.003 · Cited by 24
Alessi, A., Brandão, A. A., de Paiva, A. M. G., Nogueira, A. D. R., Feitosa, A. D. M., Gonzaga, C. C., Amodeo, C., Mion, D., de Souza, D. D. S. M., Barbosa, E. C. D., et al. (2014) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20140011 · Cited by 27
Hypomagnesemia and prehypertension in otherwise healthy individuals
Rodríguez‐Morán, M., & Guerrero‐Romero, F. (2013) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2013.08.706 · Cited by 21
“Prevalence of preHTN among adults varies from 8% to 30% [3,4] and is significantly associatedwith increased risk ofmortality by cardiovascular disease; so, preHTN should be considered as a public health problem that deserves attention in order to find alternatives for its prevention and treatment.”
BackgroundSchmieder, R. E., Ruilope, L. M., Ott, C., Mahfoud, F., & Böhm, M. (2013) · Journal of Human Hypertension · doi:10.1038/jhh.2013.39 · Cited by 20
Clinical utility of ambulatory blood pressure monitoring in the management of hypertension
Angeli, F., Reboldi, G., Poltronieri, C., Bartolini, C., D’Ambrosio, C., Filippo, V. D., & Verdecchia, P. (2014) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.2014.903155 · Cited by 21
“At least three systematic overviews [5,7,8] evaluated the prognostic impact of masked hypertension.”
BackgroundMethod
Metadata
- Authors
- Bobrie, G., Clerson, P., Ménard, J., Postel-Vinay, N., Chatellier, G., & Plouin, P.-F.
- Affiliations
- Assistance Publique – Hôpitaux de Paris (FR)
- Université Paris Descartes (FR)
- Corresponding author
- Bobrie, Guillaume
- Venue
- Journal of Hypertension
- Published
- 2008-09
- Volume
- 26
- Issue
- 9
- Pages
- 1715-1725
- ISSN
- 0263-6352 (ISSN-L)
- OpenAlex
- W1987521955
- Cited by
- 279
- References
- 64
- Citations by year
- 2026: 3 · 2025: 8 · 2024: 4 · 2023: 9 · 2022: 11 · 2021: 10 · 2020: 20 · 2019: 19 · 2018: 14 · 2017: 8 · 2016: 21 · 2015: 24 · 2014: 36 · 2013: 25 · 2012: 15
- FWCI
- 2.52
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Hypertension (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Health Sciences › Nursing › Nutrition and Dietetics › Sodium Intake and Health
- Keywords
- masked hypertension, hypertension, cardiovascular risk, cardiovascular events, prevalence, target organ damage, blood pressure measurement variability, hypertension screening, antihypertensive therapy, prognosis
- MeSH terms
- Humans, Hypertension, Kidney Diseases, Prognosis, Risk Factors, Incidence, Prevalence, Hypertrophy, Left Ventricular
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.